首页|糖尿病肾病患者采用血液灌流联合血液透析治疗的效果及对炎症因子、胰岛素抵抗的影响分析

糖尿病肾病患者采用血液灌流联合血液透析治疗的效果及对炎症因子、胰岛素抵抗的影响分析

扫码查看
目的 研究和分析糖尿病肾病(Diabetic Nephropathy,DN)患者采用血液灌流联合血液透析治疗的效果及对炎症因子、胰岛素抵抗的影响分析.方法 选取2022年1月—2023年9月日照市中心医院收治的80例DN患者为研究对象,根据单双数法分为观察组和对照组,各40例.对照组行血液透析治疗,观察组行血液灌流联合血液透析治疗.比较治疗前后两组肿瘤坏死因子-α(Tumor Necrosis Factor-α,TNF-α)、C反应蛋白(C-reactive Protein,CRP)、白介素10(Interleukin-10,IL-10)、胰岛素抵抗指数(Homeostasis Model Assessment-insulin Resistance,HOMA-IR)、空腹胰岛素(Fasting Insulin,FINS)、空腹血糖(Fasting Plasma Glucose,FPG)水平变化及临床疗效.结果 观察组治疗有效率(95.00%)高于对照组(77.00%),差异有统计学意义(x2=5.165,P<0.05).治疗后,观察组TNF-α、CRP、IL-10、HOMA-IR、FINS、FPG水平均显著降低,且变化幅度高于对照组,差异有统计学意义(P均<0.05).观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05).结论 与单纯的血液透析治疗相比,血液灌流联合血液透析可显著DN患者的治疗效果,减少炎症因子,缓解胰岛素抵抗,降低不良反应发生率.
Analysis of the Effect of Treatment with Hemoperfusion Combined with Hemodialysis in Patients with Diabetic Nephropathy and the Impact on In-flammatory Factors,Insulin Resistance
Objective To study and analyze the effect of hemoperfusion combined with hemodialysis in patients with diabetic nephropathy(DN)and the effect on inflammatory factors and insulin resistance.Methods A total of 80 DN patients admitted to Rizhao Central Hospital from January 2022 to September 2023 were selected as the research ob-jects.According to the odd and even number method,they were divided into the observation group and the control group,with 40 cases in each group.The control group was treated with hemodialysis,and the observation group was treated with hemoperfusion combined with hemodialysis.The two groups were compared before and after treatment tu-mor necrosis factor-α(TNF-α),C-reactive protein(CRP),interleukin-10(IL-10),insulin resistance index homa ir(HOMA-IR),fasting insulin(FINS),fasting plasma glucose(FPG)level changes and clinical efficacy.Results The ef-fective rate of the observation group(95.00%)was higher than that of the control group(77.00%),the difference was statistically significant(x2=5.165,P<0.05).After treatment,the levels of TNF-α,CRP,IL-10,HOMA-IR,FINS and FPG in the observation group were significantly decreased,and the changes were higher than those in the control group,and the differences were statistically significant(all P<0.05).The incidence of adverse reactions in the observa-tion group was lower than that in the control group,and the difference was statistically significant(P<0.05).Conclu-sion Compared with hemodialysis treatment alone,hemoperfusion combined with hemodialysis can significantly DN patients'therapeutic effects,reduce inflammatory factors,alleviate insulin resistance,and reduce the incidence of ad-verse reactions.

Diabetic nephropathyHemoperfusionHemodialysisInflammatory factorsInsulin resistance

孙晓伟、李慎民、牛敬然

展开 >

日照市中心医院血液透析科,山东日照 276800

糖尿病肾病 血液灌流 血液透析 炎症因子 胰岛素抵抗

2024

系统医学

系统医学

ISSN:
年,卷(期):2024.9(2)
  • 15